Last week’s behaviour of the Treasury market is puzzling for two reasons. First, a further paring back of expectations for tighter monetary policy following the Fed’s mid-week meeting might reasonably have been expected to reduce the yields of shorter-dated bonds by more than those of their longer-dated counterparts. Yet, there was a bull flattening of the yield curve out to the 6-year mark. Second, the reduction in the implied real yield of 10-year Treasuries – and in the actual real yield of 10-year TIPS – coincided with a renewed outperformance within the US stock market of some COVID-19 vulnerable sectors, amid news of a new treatment developed by Pfizer that is reportedly extremely effective at reducing the risk of hospitalisation and death from the virus. This is the opposite of what happened this spring and to a lesser extent in September.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services